Skip to content

The Impact of Exercise on Growth Hormone Deficient Adolescent and Young Adult Survivors of Childhood Cancer: a pilot study

The Impact of Exercise on Metabolic Parameters of Growth Hormone Deficient Adolescent and Young Adult Survivors of Childhood Cancer: A Randomised Cross-Over study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000796684
Acronym
GHDEx
Enrollment
30
Registered
2014-07-28
Start date
2014-03-13
Completion date
2014-09-18
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to investigate the impact of a tailored supervised exercise program on the metabolic, psychosocial and cardiovascular risk factors of adolescent and young adult survivors of childhood cancer. Who is it for? You or your child may be eligible to join this study if you/they are aged between 15-23 years and have had either brain tumours or cranial irradiation. Study details: Participants in this study will be randomly (by chance) allocated to one of two groups. The first group will take part in a 6 month supervised exercise program which is administered by an exercise physiologist (personal trainor)for 3 x 1 hour sessions per week. Participants in the other group will receive no intervention initially, but will take part in the exercise program after a period of 6 months. Proir to and on completion of the program participants will undergo clinical tests and complete some questionnaires in order to evaluate the impact of exercise on metabolic, cardiovascular and psychosocial wellbeing.

Interventions

The exercise program consists of thrice weekly supervised exercise sessions aimed at increasing exercise capacity. Each session will last for about 1 hour and consist of a small group with each participant having a personally tailored program. This will continue for 6 months. Intensity will be monitored during exercise sessions using heart rate monitors and rate of perceived exertion (Borg scale). During the intervention phase, exercise intensity will be maintained in the moderate intensity and

The exercise program consists of thrice weekly supervised exercise sessions aimed at increasing exercise capacity. Each session will last for about 1 hour and consist of a small group with each participant having a personally tailored program. This will continue for 6 months. Intensity will be monitored during exercise sessions using heart rate monitors and rate of perceived exertion (Borg scale). During the intervention phase, exercise intensity will be maintained in the moderate intensity and not enter into vigorous intensity (>60% VO2R). The key components of the exercise intervention include resistance training to increase lean muscle mass, and aerobic training to increase aerobic fitness. Each exercise program will be fully supervised and designed in accordance with the American College of Sports Medicine (ACSM) guidelines(Franklin BA, Whaley MH, and Howley ET. ACSM's Guidelines for exercise testing and prescription (6 ed.). Philadelphia: Lippincott Williams and Wilkins, 2000). The program will consist of a 10 min warm up period, with light stretching, followed by 30-45 min of a circuit-based program which will use a combination of both endurance (65-85% of HRmax, monitored continuously using a Polar heart rate monitor) and resistance (55-70% maximal voluntary contraction) exercises, and a 10 min cool down. Intensity and duration will be increased, first by extending the number of sets, then by the weight lifted. We have previous experienced high levels of compliance and participation using this form of training in a similar population group, who are young, and generally not highly motivated to participate in physical activities.

Sponsors

Princess Margaret Hospital for Children
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
15 Years to 23 Years
Healthy volunteers
No

Inclusion criteria

1. Survivor of childhood brain cancer or cranial irradiation at a dose sufficient to potentially result in GH deficiency 2. Current age 15-23

Exclusion criteria

Currently on GH therapy Acutely unwell Pregnant

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 24, 2026